Suchergebnisse - "Banach, Maciej"

PubPharm (95)

1

Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?

enthalten in: Current atherosclerosis reports | 2024

von Surma, S. | Sahebkar, A. | Banach, M.

ErratumIn: Curr Atheroscler Rep. 2024 Jan 22;:. - PMID 38252373

2

Familial hypercholesterolaemia in children and adolescents from 48 countries : a cross-sectional study

enthalten in: Lancet (London, England) | 2024

von European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration | Dharmayat, K. | Vallejo-Vaz, A. | +98

3

Evaluation of the efficacy and safety of bempedoic acid in women and men : Pooled analyses from phase 3 trials

enthalten in: Atherosclerosis | 2023

von Goldberg, A. | Banach, M. | Catapano, A. | +5

4

Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome

enthalten in: Journal of clinical lipidology | 2023

von Escobar, C. | Barrios, V. | Cequier, A. | +7

5

Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts : an Update from the Adverse Event Reporting Systems

enthalten in: Current atherosclerosis reports | 2023

von Banach, M. | Norata, G.

6

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD : A Simulation Study From DA VINCI

enthalten in: Cardiovascular drugs and therapy | 2023

von Vallejo-Vaz, A. | Bray, S. | Villa, G. | +28

7

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

enthalten in: Progress in cardiovascular diseases | 2023

von Banach, M. | Penson, P. | Farnier, M. | +9

8

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure

enthalten in: Current problems in cardiology | 2023

von Mahmoudi, A. | Butler, A. | Banach, M. | +2

9

Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol : Analysis of pooled data from four phase 3 clinical trials

enthalten in: Atherosclerosis | 2023

von Stroes, E. | Bays, H. | Banach, M. | +8

10

Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program

enthalten in: Kardiologia polska | 2023

von Nowowiejska-Wiewióra, A. | Wita, K. | Mędrala, Z. | +13

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]